"10.1371_journal.pone.0010126","plos one","2010-04-12T00:00:00Z","Ning Li; Scott Thompson; David C Schultz; Weiliang Zhu; Hualiang Jiang; Cheng Luo; Paul M Lieberman","Drug Discovery and Design Center, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China; The Wistar Institute, Philadelphia, Pennsylvania, United States of America","Conceived and designed the experiments: ST CL PML. Performed the experiments: NL ST DCS WZ HJ CL. Analyzed the data: NL ST DCS WZ HJ CL PML. Contributed reagents/materials/analysis tools: DCS HJ CL. Wrote the paper: CL PML.","Paul Lieberman has a competing interest as an officer (Founder/Owner and President) in a small biotechnology company called Vironika. A provisional patent has been submitted based on this work. No funding from Vironika was used for this study. The authors confirm that this does not alter their adherence to all the PLoS ONE policies on sharing data and materials.","2010","04","Ning Li","NL",7,TRUE,3,6,7,2,TRUE,TRUE,FALSE,0,NA,FALSE
